NFKB1 and gastric cancer: Genomically, TLS are enriched in EBV-positive, MSI-high, and PI3K-mutant gastric cancers, where TLR/NF-κB activation driven by high neoantigen loads may enhance responses to PD-1 blockade (28, 45, 58).